CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results
Titel:
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results
Auteur:
Sinn, M. Liersch, T. Riess, H. Gellert, K. Stübs, P. Waldschmidt, D. Lammert, F. Maschmeyer, G. Bechstein, W. Bitzer, M. Denzlinger, C. Hofheinz, R. Lindig, U. Ghadimi, M. Hinke, A. Striefler, J.K. Pelzer, U. Bischoff, S. Bahra, M. Oettle, H.